tiprankstipranks
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
US Market
Holding ACUR?
Track your performance easily

Acura Pharmaceuticals (ACUR) Income Statement

79 Followers

Acura Pharmaceuticals Income Statement

Last quarter (Q ), Acura Pharmaceuticals's total revenue was $36.00K, a decrease of -94.99% from the same quarter last year. In Q, Acura Pharmaceuticals's net income was $29.00K. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.56M$ 1.56M$ 3.57M$ 2.66M$ 410.00K$ 2.97M
Cost of Revenue
----$ -4.33M$ 128.00K
Gross Profit
$ 1.56M$ 1.56M$ 3.57M$ 2.66M$ 410.00K$ 2.84M
Operating Expense
$ 2.78M$ 2.78M$ 4.33M$ 3.38M$ 4.33M$ 8.06M
Operating Income
$ -1.21M$ -1.21M$ -758.00K$ -725.00K$ -3.92M$ -5.22M
Net Non Operating Interest Income Expense
$ 335.00K$ 335.00K$ -450.00K$ -449.00K$ -223.00K$ -592.00K
Other Income Expense
---$ 2.60M$ -296.00K$ -4.00K
Pretax Income
$ -879.00K$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.82M
Tax Provision
$ -97.00K$ -97.00K--$ -17.00K$ -135.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -879.00K$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.68M
Basic EPS
$ -0.02$ -0.02$ -0.04$ -0.14$ -0.18$ -0.36
Diluted EPS
$ -0.02$ -0.02$ -0.04$ -0.14$ -0.18$ -0.36
Basic Average Shares
$ 175.28M$ 56.80M$ 32.32M$ 26.72M$ 21.15M$ 15.90M
Diluted Average Shares
$ 175.28M$ 56.80M$ 32.32M$ 26.72M$ 21.15M$ 15.90M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.78M$ 2.78M$ 4.33M$ 3.38M-$ 8.19M
Net Income From Continuing And Discontinued Operation
$ -879.00K$ -879.00K$ -1.21M$ -3.77M$ -3.84M$ -5.68M
Normalized Income
------
Interest Expense
------
EBIT
$ -679.00K$ -679.00K$ -758.00K$ -3.33M$ -3.73M$ -5.22M
EBITDA
$ -589.00K$ -589.00K$ -633.00K$ -2.99M$ -3.36M$ -4.83M
Currency in USD

Acura Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis